Shufro Rose & CO LLC Novo Cure LTD Transaction History

Shufro Rose & CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$116.17 - $194.55 $151,021 - $252,915	-1,300 Closed	0 $0
Q1 2021 Apr 28, 2021	SELL	$124.11 - $190.17 $86,877 - $133,119	-700 Reduced 35.0%	1,300 $172,000
Q4 2020 Feb 03, 2021	SELL	$112.16 - $174.14 $33,648 - $52,241	-300 Reduced 13.04%	2,000 $346,000
Q3 2020 Oct 27, 2020	BUY	$58.05 - $111.31 $133,515 - $256,013	2,300 New	2,300 $256,000
Q2 2020 Aug 06, 2020	SELL	$57.2 - $74.41 $171,600 - $223,230	-3,000 Closed	0 $0
Q1 2020 Apr 22, 2020	SELL	$57.05 - $95.75 $34,230 - $57,450	-600 Reduced 16.67%	3,000 $202,000
Q3 2019 Oct 30, 2019	BUY	$61.86 - $97.8 $222,696 - $352,080	3,600 New	3,600 $269,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.69B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Shufro Rose & CO LLC with notifications on news.